TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer

Table 5

Multivariate analysis (mPFS).

Parameters	Hazard ratio	95% confidence interval	value
Infusion of CD8^+ TIL numbers (≥ vs. <)	5.823	(2.871, 11.81)	<0.0001
Infusion of CD8^+ TIL percentage (≥60% vs. <60%)	7.05	(2.813, 17.67)	<0.0001
Infusion of CD8^+PD1^+ TIL percentage (≥10% vs. <10%)	4.285	(2.697, 6.807)	<0.0001
Infusion of CD4^+FoxP3^+ TIL percentage (≥20% vs. <20%)	4.551	(2.74, 7.561)	<0.0001
HPV status (positive vs. negative)	11.84	(1.915, 73.16)	<0.0001
Fever (yes vs. no)	6.857	(2.83, 16.62)	<0.0001